Skip to content
Search

Latest Stories

RPS urges government to ban ‘diet drug’ DNP for human consumption

The Royal Pharmaceutical Society (RPS) is calling on the Home Office to ban the industrial chemical 2,4-Dinitrophenol (DNP), stating it to be unfit for human consumption.

According to National Poison Information Service report 2020/21, DNP has led to 32 deaths since 2007 among those taking it after being supplied online as a ‘diet drug’.


The main use of DNP is in the manufacture of explosives and pesticides. It can also reduce body fat by speeding up the metabolism and is sold by unscrupulous dealers to vulnerable individuals wanting to lose weight. It is highly dangerous to health and should never be used for weight loss.

Responding to the Home Office consultation on changes to the Poisons Act 1972, RPS urged the government to immediately ban DNP to reduce the danger to the public, to prosecute those seeking to profit from DNP and to encourage other countries to do the same.

Between 2007 and 2020, the UK National Poisons Information Service recorded 138 cases of poisoning due to DNP. Of those who presented at hospital between 2007 and 2019 with a history of having taken DNP, 18 per cent died.

RPS President Professor Claire Anderson said: “We welcome the fact that DNP could be added to the Poisons List, which we have been calling for since 2019. But we believe that DNP should be completely banned and not supplied under any circumstances. There is no legitimate human or animal use for DNP and over the last 15 years 32 people have died from taking it.

“We are concerned that DNP is still in circulation and often targeted to image conscious young people who may want to try quick fixes to improve their body image. Don’t ever believe what you see online about DNP – if you want to lose weight, talk to a health professional instead. You’re dicing with death if you buy DNP online.

“If the Home Office will not consider a ban, then as well as adding DNP to the Poisons List to control its supply, legislation should be passed that prohibits the compounding of DNP. This would make it illegal to put DNP into sachets or capsules for human, animal or agricultural use.”

More For You

GPhC should consider reduced fees for pharmacists non-practising practising, says RPS

RPS responds to GPhC consultation on draft changes to fees

gettyimages

RPS urges GPhC to reduce registration fees for non-practising pharmacists

The Royal Pharmaceutical Society (RPS) has called on the General Pharmaceutical Council (GPhC) to reduce annual registration fees for non-practising pharmacists — such as those on parental leave or with a long-term illness — in response to the regulator’s consultation on proposed changes to fees.

The GPhC is proposing a 6% increase in annual registration fees from September 2025 to cover the rising operational costs.

Keep ReadingShow less
Nick Kaye
Nick Kaye appointed as NPA's new chair
Nick Kaye appointed as NPA's new chair

Breaking news: NPA members advised against collective action

With the government’s recent announcement of increased funding to the sector signalling a ‘clear step forward’, the National Pharmacy Association (NPA) has today announced that it will not be recommending collective action to its members.

Last month, the department of health announced the Community Pharmacy Contractual Framework (CPCF) with an increase in funding for 2024/25 of £106m to £2.7 billion and simultaneously a further increase to £3.1 billion for 25/26.

Keep ReadingShow less
Slamannan Village Pharmacy sold after 31 years

Slamannan Village Pharmacy

Slamannan Village Pharmacy sold after 31 years

A pharmacy in a small village in Scotland that has served its community for 31 years, has been bought by a group that operates 43 pharmacies across Scotland.

Slamannan Village Pharmacy is heavily relied on by locals sourcing their prescriptions from the village’s sole GP surgery.

Keep ReadingShow less
Kinnock highlights employers’ role in making community pharmacy jobs attractive

The new funding uplift our commitment to rebuilding the sector: Kinnock

Kinnock: ‘Employers have a key role in making community pharmacy jobs attractive’

Health minister Stephen Kinnock has emphasised that employers have a crucial role to play in retaining staff and making careers in community pharmacy more attractive.

His comments came in response to a written question from Victoria Collins MP, the Liberal Democrat spokesperson for science and technology, who asked what steps the Department of Health and Social Care is taking to address staff shortages and prevent the closure of local pharmacies.

Keep ReadingShow less
​Pope Francis

Pope Francis at the Vatican on December 4, 2024.

Photo by FILIPPO MONTEFORTE/AFP via Getty Images

His Holiness Mahant Swami Maharaj offers condolences to Catholic community following Pope Francis' passing

His Holiness Mahant Swami Maharaj, the spiritual leader and president of the Bochasanwasi Akshar Purushottam Swaminarayan Sanstha (BAPS), has expressed heartfelt condolences to the Catholic community worldwide following the passing of Pope Francis on Monday.

In a formal letter addressed to the members of the Roman Catholic Church, Mahant Swami Maharaj conveyed the deep sorrow of the BAPS Swaminarayan Hindu fellowship, acknowledging the Pope's passing as “a profound loss to the Catholic community and Christians around the world.”

Keep ReadingShow less